MIRA Pharmaceuticals, Inc.
MIRA
$1.42
-$0.01-0.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -29.57% | -5.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.35% | -25.95% | |||
| Operating Income | 14.35% | 25.95% | |||
| Income Before Tax | 13.80% | 25.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.80% | 25.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.80% | 25.67% | |||
| EBIT | 14.35% | 25.95% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 15.58% | 26.02% | |||
| Normalized Basic EPS | 15.52% | 26.05% | |||
| EPS Diluted | 15.58% | 26.02% | |||
| Normalized Diluted EPS | 15.52% | 26.05% | |||
| Average Basic Shares Outstanding | 2.05% | 0.51% | |||
| Average Diluted Shares Outstanding | 2.05% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||